Literature DB >> 3768252

Excretion of trazodone in breast milk.

R K Verbeeck, S G Ross, E A McKenna.   

Abstract

The excretion of breast milk was studied in six lactating women following the oral administration of a single trazodone tablet (50 mg). The milk/plasma ratio of trazodone based on area under the plasma and milk curves was small: 0.142 +/- 0.045 (mean +/- s.d.). Assuming that the babies would drink 500 ml 12 h-1, they would be exposed to less than 0.005 mg kg-1 as compared to 0.77 mg kg-1 for the mothers. It is concluded that exposure of babies to trazodone via breast milk is very small.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3768252      PMCID: PMC1401139          DOI: 10.1111/j.1365-2125.1986.tb02903.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  10 in total

1.  (--)-m-Chlorophenyl-piperazine, a central 5-hydroxytryptamine agonist, is a metabolite of trazodone.

Authors:  S Caccia; M Ballabio; R Samanin; M G Zanini; S Garattini
Journal:  J Pharm Pharmacol       Date:  1981-07       Impact factor: 3.765

2.  Studies on metabolism of trazodone. III Species differences.

Authors:  C Yamato; T Takahashi; T Fujita
Journal:  Xenobiotica       Date:  1976-05       Impact factor: 1.908

3.  Pharmacokinetic and pharmacodynamic characteristics of trazodone in the elderly.

Authors:  A J Bayer; M S Pathy; S I Ankier
Journal:  Br J Clin Pharmacol       Date:  1983-10       Impact factor: 4.335

4.  Drug distribution within human milk phases.

Authors:  G B Syversen; S K Ratkje
Journal:  J Pharm Sci       Date:  1985-10       Impact factor: 3.534

5.  Lack of anticholinergic side effects with a new antidepressent--trazodone.

Authors:  S Gershon; R Newton
Journal:  J Clin Psychiatry       Date:  1980-03       Impact factor: 4.384

Review 6.  Excretion of drugs in human breast milk.

Authors:  R M Welch; J W Findlay
Journal:  Drug Metab Rev       Date:  1981       Impact factor: 4.518

7.  Infant growth and human milk requirements. A fresh approach.

Authors:  R G Whitehead; A A Paul
Journal:  Lancet       Date:  1981-07-25       Impact factor: 79.321

Review 8.  Drug excretion in human breast milk: principles, pharmacokinetics and projected consequences.

Authors:  J T Wilson; R D Brown; D R Cherek; J W Dailey; B Hilman; P C Jobe; B R Manno; J E Manno; H M Redetzki; J J Stewart
Journal:  Clin Pharmacokinet       Date:  1980 Jan-Feb       Impact factor: 6.447

9.  Comparative bioavailability of trazodone formulations using stable isotope methodology.

Authors:  R E Gammans; A V Mackenthun; J W Russell
Journal:  Br J Clin Pharmacol       Date:  1984-09       Impact factor: 4.335

Review 10.  Trazodone: a review of its pharmacological properties and therapeutic use in depression and anxiety.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1981-06       Impact factor: 9.546

  10 in total
  19 in total

Review 1.  Antidepressants and breast-feeding: a review of the literature.

Authors:  S Dodd; A Buist; T R Norman
Journal:  Paediatr Drugs       Date:  2000 May-Jun       Impact factor: 3.022

Review 2.  Depression in childbearing women: when depression complicates pregnancy.

Authors:  Sheila M Marcus; Julie E Heringhausen
Journal:  Prim Care       Date:  2009-03       Impact factor: 2.907

Review 3.  Prenatal antidepressant exposure: clinical and preclinical findings.

Authors:  Chase H Bourke; Zachary N Stowe; Michael J Owens
Journal:  Pharmacol Rev       Date:  2014-02-24       Impact factor: 25.468

4.  Prediction of drug distribution into human milk from physicochemical characteristics.

Authors:  H C Atkinson; E J Begg
Journal:  Clin Pharmacokinet       Date:  1990-02       Impact factor: 6.447

Review 5.  Depression During Pregnancy and Postpartum.

Authors:  Madeleine Becker; Tal Weinberger; Ann Chandy; Sarah Schmukler
Journal:  Curr Psychiatry Rep       Date:  2016-03       Impact factor: 5.285

Review 6.  Benefits and risks to mother and infant of drug treatment for postnatal depression.

Authors:  Shaila Misri; Xanthoula Kostaras
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

Review 7.  Psychotropic Treatment During Pregnancy: Research Synthesis and Clinical Care Principles.

Authors:  Hannah K Betcher; Katherine L Wisner
Journal:  J Womens Health (Larchmt)       Date:  2019-12-03       Impact factor: 2.681

Review 8.  Lactation studies of anticonvulsants: a quality review.

Authors:  Douwe H van der Meer; Andre Wieringa; Ilse Wegner; Bob Wilffert; Peter G J Ter Horst
Journal:  Br J Clin Pharmacol       Date:  2015-04       Impact factor: 4.335

9.  When depression complicates childbearing: guidelines for screening and treatment during antenatal and postpartum obstetric care.

Authors:  Maria Muzik; Sheila M Marcus; Julie E Heringhausen; Heather Flynn
Journal:  Obstet Gynecol Clin North Am       Date:  2009-12       Impact factor: 2.844

Review 10.  Drugs in human milk. Clinical pharmacokinetic considerations.

Authors:  H C Atkinson; E J Begg; B A Darlow
Journal:  Clin Pharmacokinet       Date:  1988-04       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.